Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Caffeine for Late Preterm Infants: A Double Blind Randomized Controlled Trial

NCT06026163 is registered in ClinicalTrials.gov with Ministry of Health, Saudi Arabia as lead sponsor.

NCT NCT06026163
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06026163 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Caffeine for Late Preterm Infants: A Double Blind Randomized Controlled Trial
Lead sponsor
Ministry of Health, Saudi Arabia
Phase
Phase 2/3
Overall status
Recruiting
Start date
October 12, 2023
Completion date
January 1, 2028
Enrollment
134 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

prematurity, respiratory disease, ventilator lung; newborn